The University of Chicago Header Logo

Connection

Sangeeta Bhorade to Lung Transplantation

Back to Details
This is a "connection" page, showing publications Sangeeta Bhorade has written about Lung Transplantation.
Sangeeta Bhorade
Connection Strength
7.785
Lung Transplantation
  1. Frailty and aging-associated syndromes in lung transplant candidates and recipients. Am J Transplant. 2021 06; 21(6):2018-2024.
    View in: PubMed
    Score: 0.461
  2. Lung transplantation in scleroderma: recent advances and lessons. Curr Opin Rheumatol. 2018 11; 30(6):562-569.
    View in: PubMed
    Score: 0.397
  3. Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation. PLoS One. 2014; 9(7):e103643.
    View in: PubMed
    Score: 0.296
  4. The lung microbiome after lung transplantation. Expert Rev Respir Med. 2014 Apr; 8(2):221-31.
    View in: PubMed
    Score: 0.289
  5. Invited commentary. Ann Thorac Surg. 2014 Jan; 97(1):274-5.
    View in: PubMed
    Score: 0.284
  6. Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation. Chest. 2013 Jun; 143(6):1717-1724.
    View in: PubMed
    Score: 0.273
  7. Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation. J Heart Lung Transplant. 2013 Jul; 32(7):701-6.
    View in: PubMed
    Score: 0.272
  8. A longitudinal study of patients' symptoms before and during the first year after lung transplantation. Clin Transplant. 2012 Nov-Dec; 26(6):E576-89.
    View in: PubMed
    Score: 0.260
  9. Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation. J Heart Lung Transplant. 2011 Feb; 30(2):175-81.
    View in: PubMed
    Score: 0.227
  10. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation. 2010 Sep 15; 90(5):540-6.
    View in: PubMed
    Score: 0.226
  11. Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. Am J Respir Crit Care Med. 2011 Feb 01; 183(3):379-87.
    View in: PubMed
    Score: 0.226
  12. Current trends in immunosuppression for lung transplantation. Semin Respir Crit Care Med. 2010 Apr; 31(2):172-8.
    View in: PubMed
    Score: 0.219
  13. Immunosuppression for lung transplantation. Proc Am Thorac Soc. 2009 Jan 15; 6(1):47-53.
    View in: PubMed
    Score: 0.202
  14. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant. 2008 Sep; 27(9):990-4.
    View in: PubMed
    Score: 0.196
  15. Elevation of interleukin-15 protein expression in bronchoalveolar fluid in acute lung allograft rejection. Chest. 2007 Feb; 131(2):533-8.
    View in: PubMed
    Score: 0.176
  16. Evolving immunosuppressive regimens for lung transplant recipients. Semin Respir Crit Care Med. 2006 Oct; 27(5):470-9.
    View in: PubMed
    Score: 0.172
  17. Sequential gene expression profiling in lung transplant recipients with chronic rejection. Chest. 2006 Sep; 130(3):847-54.
    View in: PubMed
    Score: 0.171
  18. Utility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era. J Heart Lung Transplant. 2026 08; 45(8):1251-1269.
    View in: PubMed
    Score: 0.166
  19. Different States of Lung Allograft Injury Assessed by Plasma Donor-Derived and Total Cell-Free DNA. J Mol Diagn. 2026 May; 28(5):429-438.
    View in: PubMed
    Score: 0.165
  20. Successful use in lung transplantation of an immunosuppressive regimen aimed at reducing target blood levels of sirolimus and tacrolimus. J Heart Lung Transplant. 2005 Apr; 24(4):421-5.
    View in: PubMed
    Score: 0.155
  21. Lung transplantation for interstitial lung disease. Clin Chest Med. 2004 Dec; 25(4):773-82, vii-viii.
    View in: PubMed
    Score: 0.151
  22. Immunosuppressive regimens in lung transplant recipients. Drugs Today (Barc). 2004 Dec; 40(12):1003-12.
    View in: PubMed
    Score: 0.151
  23. Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. Am J Transplant. 2003 Dec; 3(12):1570-5.
    View in: PubMed
    Score: 0.141
  24. Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients. J Heart Lung Transplant. 2002 Dec; 21(12):1274-82.
    View in: PubMed
    Score: 0.132
  25. Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients. J Heart Lung Transplant. 2001 Sep; 20(9):928-34.
    View in: PubMed
    Score: 0.121
  26. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements. J Heart Lung Transplant. 2021 11; 40(11):1251-1266.
    View in: PubMed
    Score: 0.120
  27. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000 Dec; 19(12):1199-204.
    View in: PubMed
    Score: 0.115
  28. Clinical relevance of lung-restricted antibodies in lung transplantation. Hum Immunol. 2019 Aug; 80(8):595-601.
    View in: PubMed
    Score: 0.103
  29. Lung transplantation at Loyola University Medical Center. Clin Transpl. 1999; 281-8.
    View in: PubMed
    Score: 0.100
  30. Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. Am J Respir Crit Care Med. 2018 01 15; 197(2):235-243.
    View in: PubMed
    Score: 0.094
  31. Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension. Ann Am Thorac Soc. 2017 Oct; 14(10):1514-1522.
    View in: PubMed
    Score: 0.092
  32. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia. J Heart Lung Transplant. 2016 Apr; 35(4):500-507.
    View in: PubMed
    Score: 0.082
  33. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk. Am J Transplant. 2016 Mar; 16(3):833-40.
    View in: PubMed
    Score: 0.081
  34. Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation. Am J Transplant. 2015 Aug; 15(8):2188-96.
    View in: PubMed
    Score: 0.078
  35. Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey. J Heart Lung Transplant. 2015 Jan; 34(1):65-74.
    View in: PubMed
    Score: 0.075
  36. Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation. Am J Respir Crit Care Med. 2014 Jun 15; 189(12):1564-7.
    View in: PubMed
    Score: 0.073
  37. Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction. Am J Respir Crit Care Med. 2014 Mar 01; 189(5):567-75.
    View in: PubMed
    Score: 0.072
  38. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation. Am J Transplant. 2014 Feb; 14(2):446-52.
    View in: PubMed
    Score: 0.071
  39. Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest. 2013 Aug; 144(2):616-622.
    View in: PubMed
    Score: 0.069
  40. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013 Mar 01; 187(5):527-34.
    View in: PubMed
    Score: 0.066
  41. Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation. PLoS One. 2012; 7(12):e51932.
    View in: PubMed
    Score: 0.066
  42. Executive summary: monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Nov; 142(5):1284-1288.
    View in: PubMed
    Score: 0.066
  43. Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Nov; 142(5):e1S-e111S.
    View in: PubMed
    Score: 0.066
  44. SaLUTaRy: survey of lung transplant rejection. J Heart Lung Transplant. 2012 Sep; 31(9):972-9.
    View in: PubMed
    Score: 0.065
  45. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2012 Sep 15; 186(6):546-52.
    View in: PubMed
    Score: 0.064
  46. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. J Heart Lung Transplant. 2012 Sep; 31(9):942-9.
    View in: PubMed
    Score: 0.064
  47. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med. 2011 Nov 01; 184(9):1055-61.
    View in: PubMed
    Score: 0.061
  48. Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis. Am J Transplant. 2011 Nov; 11(11):2517-22.
    View in: PubMed
    Score: 0.060
  49. Conventional and novel approaches to immunosuppression. Clin Chest Med. 2011 Jun; 32(2):265-77.
    View in: PubMed
    Score: 0.059
  50. Differentiated transplant derived airway epithelial cell cytokine secretion is not regulated by cyclosporine. Respir Res. 2011 Apr 10; 12:44.
    View in: PubMed
    Score: 0.059
  51. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis. Chest. 2011 Aug; 140(2):489-496.
    View in: PubMed
    Score: 0.058
  52. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction. Am J Transplant. 2011 Mar; 11(3):561-7.
    View in: PubMed
    Score: 0.058
  53. Early readmission is a predictor of overall survival following isolated lung transplantation. Int Surg. 2010 Oct-Dec; 95(4):299-304.
    View in: PubMed
    Score: 0.057
  54. Clinical pathway after lung transplantation shortens hospital length of stay without affecting outcome. Int Surg. 2007 Mar-Apr; 92(2):93-8.
    View in: PubMed
    Score: 0.044
  55. Thoracic organ transplantation in the United States, 1995-2004. Am J Transplant. 2006; 6(5 Pt 2):1188-97.
    View in: PubMed
    Score: 0.041
  56. Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation. 2001 Mar 27; 71(6):773-7.
    View in: PubMed
    Score: 0.029
  57. Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant. 2000; 5(3):44-7.
    View in: PubMed
    Score: 0.027
  58. Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans. Sci Transl Med. 2015 Apr 22; 7(284):284re3.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.